Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
AI-Driven Facilities: Strategic Planning and Cost Management 
Double Homicide Suspect Hides from Police in Upstate Community Hospital
McCarthy and HOK Break Ground on Kedren Children's Village
Thousands of Healthcare Workers Laid Off
Construction Tops Off at Hackensack Meridian Health and Wellness Center